Aztreonam (100 mg) is a monobactam antibiotic, laboratory grade, designed primarily for antibacterial research. This product is formulated to be a highly effective antibacterial agent, particularly useful for the treatment of Gram-negative bacterial infections. Aztreonam acts by inhibiting bacterial cell wall synthesis, which is essential for bacterial survival. It is commonly used in laboratory research to study the bactericidal properties and effectiveness of antibiotics. This reagent can be employed in in vitro experiments focused on antibiotic resistance mechanisms, pharmacodynamics, and testing of novel antibiotic compounds in antibacterial research.